Stocks making the biggest moves midday: SpaceX, Apple, PayPal, Cava, Progressive, Micron & more

PayPal surged about 17% on a reported potential buyout by Stripe and Advent, valuing the offer at $53B and pricing at $60.50/share. Offsetting declines were led by Pentair, down more than 17% after preliminary 2Q results and adjusted EPS of $1.12 vs $1.48 expected, while Progressive fell over 7% after June income dropped 31% and its combined ratio rose to 90 from 86.6. Apple added ~4% after Apple Intelligence cleared a major China regulatory hurdle, lifting Alibaba (+5%) and Baidu (+2%), while BlackRock jumped ~7% on adjusted EPS of $13.91 vs $12.59 expected.

Analysis

The cleanest signal is not the headline winners but the shift in revenue-quality perception. AAPL gets a multiple-supportive de-risking in China, but the real cash flow impact is deferred until there is a launch cadence and monetization path; absent that, the move is mostly sentiment and could fade if Apple Intelligence is treated as a policy win rather than an earnings driver. BABA/BIDU are being paid as local toll collectors, but the market may be overestimating the margin pool they can capture versus the strategic control Apple retains.

The memory tape looks like an early repricing of cycle risk, not a confirmed downcycle. SNDK is the more fragile name because NAND pricing can re-rate violently on any supply narrative, while WDC is somewhat insulated if enterprise storage demand stays tied to AI capex. If CXMT is more about a listing-driven narrative than a real near-term capacity surge, the selloff could reverse quickly; the falsifier is continued stable contract pricing into the next industry update.

In insurance, PGR’s monthly deterioration matters because it can force the whole complex to re-think underwriting discipline, but one month is not a thesis. If the combined-ratio trend persists into the next 1-2 reports, PGR/ALL are exposed to multiple compression, while AON should remain relatively insulated as a fee-based beneficiary of firmer pricing. ELV is the most interesting bearish tell: the market is saying medical cost trend is becoming a multi-quarter headwind, and that can keep the stock under pressure even with raised guidance. LCID remains a financing story, not a fundamental one; denial of bankruptcy reduces immediate tail risk but does not eliminate dilution risk over the next 6-12 months.

Key Decisions for Investors

• Long AAPL on pullbacks over the next 1-3 weeks; use call spreads rather than stock if you want to express China AI de-risking without paying full multiple. Falsify if no launch timeline emerges or China approval becomes a one-off headline.
• Tactical short SNDK on strength, ideally via 1-2 month put spreads; this is the most directly vulnerable memory name if the China supply narrative broadens. Cover if contract pricing or management commentary shows no ASP compression.
• Pair trade: long AON / short PGR for 1-3 months. Thesis is that AON’s fee stream is less exposed to claims volatility while PGR is the first place underwriting slippage gets punished. Exit if PGR’s next monthly loss metrics normalize.
• Long BLK on any market dip over the next 2-4 weeks; earnings quality and operating leverage look better than the banking complex. If rates/markets weaken sharply, reduce exposure because fee growth is still beta-sensitive.
• Avoid chasing LCID common after the squeeze; if trading it at all, treat it as a high-beta event trade with tight stops, since the next catalyst is likely financing/dilution rather than operating inflection.